{"id":"W4412441076","doi":"10.1016/j.msard.2025.106616","title":"Ponesimod as add-on treatment in patients with active relapsing multiple sclerosis under dimethyl fumarate (POINT): A phase 3, randomized, placebo-controlled clinical trial","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital","funders":"Actelion Pharmaceuticals; Janssen Research and Development; Johnson and Johnson","keywords":"Medicine; Dimethyl fumarate; Multiple sclerosis; Placebo; Clinical endpoint; Randomized controlled trial; Clinical trial; Internal medicine; Phases of clinical research; Oncology; Immunology; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001559415,0.001717975,0.003679853,0.00058401,0.0005302752,0.0009319648,0.0009221555,0.001846862,0.00582281],"category_scores_gemma":[0.001395955,0.000526,0.002096403,0.0004347517,0.001142148,0.00147152,0.0004100742,0.002972091,0.0007500906],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005123683,"about_ca_system_score_gemma":0.0008914104,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008578774,"about_ca_topic_score_gemma":0.001585565,"domain_scores_codex":[0.9996067,0.0001758778,0.00002503656,0.00006833686,0.00003632529,0.00008776518],"domain_scores_gemma":[0.9993528,0.0001968012,0.0001141389,0.00003977099,0.00005089839,0.0002457157],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9676428,0.006218408,0.0004219598,0.0009264593,0.0009661742,0.00006611524,0.00006440814,0.0002200599,0.003115259,0.0001064001,0.0005118368,0.01973991],"study_design_scores_gemma":[0.9193021,0.07779187,0.001394618,0.00003213191,0.0004646073,0.0000362299,0.00003106681,0.0001965206,0.0003177317,0.0001058886,0.0003156811,0.00001155105],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9864163,0.006814393,0.0005850309,0.0005918305,0.000558247,0.002645547,0.0006460194,0.0001647737,0.001577822],"genre_scores_gemma":[0.9858059,0.006118272,0.001363313,0.0008729803,0.0005513295,0.002396062,0.0008079807,0.00002406781,0.00206021],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00582281,"threshold_uncertainty_score":0.01947922,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04708319287789179,"score_gpt":0.3306873086080997,"score_spread":0.2836041157302079,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}